The lawsuits claim that Novo Nordisk failed to warn patients and the medical community about the risk of NAION, despite growing evidence from multiple studies
Capping more than two years of stock-gyrating drama, Pfizer said Monday that it would stop development of danuglipron, its experimental oral GLP-1 medicine to treat obesity, focusing its efforts on another medicine with a different mechanism of action
Frequency Guidelines for Combination Therapy The number of injections needed can change
A daily supplement of 2,500-5,000 mcg of biotin is generally safe, but there is a critical caveat that every patient and prescriber should know about
Contact your provider immediately if you experience severe cramping, persistent diarrhea despite laxative cessation, signs of dehydration, or unexplained changes in semaglutide tolerability
Milligrams (mg) This is how peptide powder is measured